News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

iSonea Limited Adds Dr. David Dantzker to Board of Directors


3/21/2012 7:35:58 AM

SEVERNA PARK, Md.--(BUSINESS WIRE)--Medical technology company iSonea Ltd. (ASX: ISN; OTCQX: ISOAY) today announced that David R. Dantzker, M.D., general partner at Wheatley Partners, LP, and former Chairman of Pulmonary Disease for the American Board of Internal Medicine, has joined iSonea’s Board of Directors (BOD).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES